Imprint and Disclaimer
The host of this Internet website is the Boehringer Ingelheim Fonds, Stiftung für medizinische Grundlagenforschung, to be rendered in English as the "Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine".
Boehringer Ingelheim Fonds
Stiftung für medizinische Grundlagenforschung
tel. +49 (0) 6131 / 27 50 8-0
fax: +49 (0) 6131 / 27 50 8-11
The Boehringer Ingelheim Fonds, a public foundation subject to German civil law and approved by the District Government of Rheinhessen/Pfalz, Germany, on February 1983, is an independent, non-profit-making institution dedicated to the promotion of basic research in medicine. The Foundation is registered in Ingelheim am Rhein, Germany.
Representatives and Organs of the Foundation
The Board of Trustees of the Boehringer Ingelheim Fonds decides on all matters of the Foundation of fundamental significance. The members of the Board of Trustees are Professor Dr. Dr. Andreas Barner, Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany; Professor Dr. Peter Herrlich, Research Centre Karlsruhe, Karlsruhe, Germany; Professor Dr. Ruth Lehmann, New York University, New York, NY, USA; Professor Dr. U. Benjamin Kaupp, Centre of Advanced European Studies and Research, Bonn, Germany; Dr. Jan-Michael Peters, Research Institute of Molecular Pathology, Vienna, Austria; Professor Dr. Hidde Ploegh, Harvard Medical School Boston, MA, USA; Professor Dr. Tilman Sauerbruch, University Bonn, Bonn, Germany; Dr. Ingrid Ohlert, Deutsche Forschungsgemeinschaft, Bonn, Germany (permanent guest). At least two members of the Executive Committee, consisting of three members of the Board of Trustees (Professor Dr. Dr. Andreas Barner, Professor Dr. Peter Herrlich, Dr. Jan-Michael Peters) represent the Foundation in legal and non-legal matters. The Managing Director, Dr. Claudia Walther, runs the regular business of the Foundation.
Responsible for the content of this Internet website of the Boehringer Ingelheim Fonds is Dr. Claudia Walther.
Kathrin Kreft, Karlsruhe, Germany
trilobit GmbH, Karlsruhe, Germany
The Boehringer Ingelheim Fonds makes every effort to provide timely and accurate information. Nevertheless, mistakes and misunderstandings cannot be ruled out. The Boehringer Ingelheim Fonds does not assume liability for relevance, accuracy, topicality and completeness of the information provided. The Boehringer Ingelheim Fonds reserves the right to alter, supplement, or delete some or all of the information on its Internet website without notice. Similarly, the Boehringer Ingelheim Fonds reserves the right to temporarily or permanently discontinue its Internet website. The Boehringer Ingelheim Fonds has no influence whatsoever on contents derived from other sources accessed by direct or indirect connections, e.g. links. Such contents are indicated appropriately. Individuals or organizations providing information on the internet are responsible for illegal and punishable contents derived from other sources (via direct or indirect connections) only if they are aware of the nature of such contents on these websites. The Boehringer Ingelheim Fonds has no knowledge of illegal or offensive contents contained in websites from other information providers. In the event of these contents being illegal and offensive, the Boehringer Ingelheim Fonds dissociates itself from them.
The layout, graphics, photos and other contents of this website are protected by copyright law. ©Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine, Heidesheim, Germany. All rights reserved.